![]() |
|
Slide 1 . Doxil ® (doxorubicin HCl liposome injection) Doxil in the Treatment of Advanced, Metastatic Ovarian Cancer . Oncologic Drugs Advisory Committee Meeting
3521S2_01_ALZA.ppt - Search
slide
doxorubicin
liposome
treatment
metastatic
ovarian
cancer
oncologic
drugs
advisory
committee
Accelerated Approval March 12-13, 2003 DOXIL® (doxorubicin HCl liposome injection) Treatment of Advanced, Metastatic Ovarian Cancer Individuals Available for ...
Doxil . E.Q. 45 y.o. papillary serous. Diagnosis 2/1/94. Cumulative dose=880mg/m 2 . Relapse 6 months from ABMT . New LLQ mass & liver mets . CA 125 (U/mL)
Slide 7 Slide 8 Modes of Liposome/Cell Interaction Classes of Liposomes Liposomes Help Improve Current liposomal drug preparations CFTR Doxil Amphotericin B ...
Critical Path Research Opportunities in the Development of Nanotechnology-Based Medicine – Lessons Learned from DOXIL® Development Tony Huang, Ph.D.
FDA_ANHMt_AHuang.ppt - Search
critical
research
opportunities
development
nanotechnology-based
medicine
lessons
learned
Doxil ®: liposomal formulation of doxorubicin (100 nm). Approved in February, 2005. http://www.doxil.com/images/clientChart.gif . http://www.abraxane.com/images_charts ...
... therapeutic, no need to repeat Phase 1, 2, 3 trials More than 100 therapeutics approved Often used for alternative delivery systems Examples – Abraxane, Doxil, ANX ...
cornwall_keystone-nano-10-25.ppt - Search
repeat
phase
trials
therapeutics
approved
often
alternative
delivery
systems
examples
... Prof. Yechezkel Barenholz Department of Biochemistry Faculty of Medicine The Hebrew University Of Jerusalem 2007 sales $417 million Success Stories - Doxil * For ...
caelyx/doxil 50 mg/m 2 q4 weekly . n = 90, recruitment complete . primary end point = PFS . statistical analysis: combined olaparib arms vs caelyx/doxil, aimed at detecting ...
Oza.ppt - Search
weekly
recruitment
complete
primary
point
statistical
combined
olaparib
aimed
detecting
... Paclitaxel and Fluorouracil Following Surgery in Treating Patients With Peritoneal Cancer National Center for Research Resources (NCRR Phase I/II Trial of Doxil and ...
... Hycamtin (topotecan HCl for injection) is indicated as a single agent (one drug) for the treatment of ovarian cancer upon failure of first-line therapy; and Doxil ...
Alkylator therapy Dex-based Thal-based Thalidomide Combinations Relapsed/Refractory Myeloma Many combination reported CTD, 1,2 DVd-T,3 VTD4,5, Velcade + Doxil + thal6 ...
Doxil ® (liposomal doxorubicin HCl - Alza) Engerix-B ® (r-Hep B vaccine - SKB) Bioinformatics; Celera Discovery System(TM) Compugen
Associated with certain agents; Capecitabine (Xeloda) Liposomal doxorubicin (Doxil) Infusional 5-FU; Weekly taxane therapy
... sensitive +/- Cytoreduction Paclitaxel Doublet Carboplatin Paclitaxel I Gemcitabine Doublet Carboplatin Gemcitabine II Doxil Doublet Carboplatin Doxil ...
20101015ELE-GynecologicCancerUpdate2010.ppt - Search
sensitive
cytoreduction
paclitaxel
doublet
carboplatin
gemcitabine
Pegylated liposomal doxorubicin (Doxil) Has been studied most extensively and has demonstrated the most significant reductions in heart problems
... AmBisome Drug: doxorubicin Chemotherapy agent for ovarian cancer Name of product: Doxcil Reduced cardiotoxicity Http://www.doxil.com Nano Carriers Example: Doxil ...
Provincia di Milano - la Provincia in casa ... La pagina richiesta non è stata trovata su questo server. il sito è stato recentemente ristrutturato ed alcune ...
DOXIL® % Doxorubicin Released . Temperature C° Clinically heatable temperature range 39°C - 42°C . Body temperature 37°C . IN VITRO Drug release occurs at clinically
Investor_presentation_3_10_08.ppt - Search
released
temperature
clinically
heatable
range
vitro
release
occurs
... heat Dendrimers Drug delivery, imaging agents VivaGel (SPL 7013) Fullerenes Drug delivery, therapeutics Antioxidant fullerene Lipsomes Drug delivery Doxil ...
|
Hot Documents poluentesstillwell bahan-kuliah-manajemen-strategi-ppt perkotaan desear 活動作品 sanritz pronósticos-en-la-producción pump-hydraulic portaria-conjunta |